Review
Copyright ©The Author(s) 2016.
World J Gastroenterol. Sep 21, 2016; 22(35): 7868-7881
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7868
Table 1 Clinical impact of obesity on inflammatory bowel disease
Medical therapySurgical therapyNatural history and disease complications
Decreased clinical response to azathioprine[77]Earlier time to 1st surgery[15]Conflicting data:
Lower 6-thioguanine levels on treatment with azathioprine[78]Higher rate of perioperative complications[112,114,119-121]Higher prevalence of perianal disease[22]
Decrease likelihood of response to adalimumab[83]Increased need for conversion from laparoscopic to open surgery[113,118]Lower prevalence of penetrating disease[24]
Shorter time to loss of response to infliximab[92]Increased hospitalization[22]
Decreased IBD-related quality of life[23]
Decreased healthcare utilization[14]